Odyssey Therapeutics, Inc.

NASDAQ:ODTX

Biotechnology

Healthcare
$18.98 -0.05%

-$0.01 today

Market cap
$912.33M
Beta
0.00
52W Low $15.35High $20.30

Volume 0.37M

Average 0.43M

ODTX Depreciation & Amortization

Non-cash expense that spreads the cost of physical and intangible assets over their useful lives.

No reported Depreciation & Amortization figures are available to summarize.

Depreciation & Amortization history

Currency unavailable · from the income statement

No Depreciation & Amortization data reported for this period type.

Depreciation & Amortization vs competitors

How ODTX compares with its peers on the latest reported figures

ODTX Competitors
Depreciation & Amortization for ODTX and competitors
Company Period LTM YoY 3-year CAGR% of revenue
ALMSAlumis Inc. Common StockLTM Jun 2026$2.65M USD-20.7%+140.9%35.9%
ANABAnaptysBio, Inc.LTM Mar 2026$2.43M USD+1.2%+1.2%1.0%
PTGXProtagonist Therapeutics, Inc.LTM Jun 2026$1.54M USD-10.7%-27.6%0.5%
ACRSAclaris Therapeutics, Inc.LTM Mar 2026$528K USD+7.3%-17.1%6.3%
AGMBAgomAb Therapeutics N.V. American Depositary SharesFY2024€311K EUR+214.1%——
ORKAOruka Therapeutics, Inc.LTM Sep 2026$163K USD+129.6%-10.0%—
IMUXImmunic, Inc.LTM Mar 2026$158K USD+4.6%+29.7%—
SYRESpyre Therapeutics, Inc.LTM Sep 2026$0 USD—+72.0%0.0%
ODTXOdyssey Therapeutics, Inc.—— ———
Peer median (excluding ODTX) —+4.6%+1.2%1.0%

Competitors are the stored peer set for ODTX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Odyssey Therapeutics, Inc.

NASDAQ:ODTX

Intrinsic Alpha fair value

Locked

Current Price

$18.98

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.